METASTATIC ESOPHAGEAL ADENOCARCINOMA
Clinical trials for METASTATIC ESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat esophageal cancer?
Disease control OngoingThis study tested if adding a new drug called cixutumumab to standard chemotherapy (paclitaxel) works better for people with advanced esophageal cancer that has spread. It involved 94 patients whose cancer had worsened after one prior treatment. The goal was to see if the combina…
Matched conditions: METASTATIC ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Radiation blitz tested to control spreading stomach cancer
Disease control OngoingThis study is for people with advanced stomach or esophageal cancer that has spread to only a few other places in the body. It tests if adding a short course of targeted radiation to standard chemotherapy works better than chemotherapy alone to control the cancer and help patient…
Matched conditions: METASTATIC ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug duo tested in fight against tough stomach cancers
Disease control OngoingThis early-stage study is testing the safety of combining two drugs, abemaciclib and ramucirumab, for people with advanced stomach or esophageal cancer that has spread and stopped responding to initial chemotherapy. The main goal is to see how safe the combination is and what sid…
Matched conditions: METASTATIC ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC